- Solutions
- Routes of DeliveryOral, Nasal, Pulmonary & Parenteral
- Development stagePre-clinical to market
-
-
WHITEPAPER
Transitioning from Phase I to Phase II
Our guide on Phase I outcomes and next steps
Learn more →
-
- Enabling Technology & PlatformsSpray-drying and development platforms
-
- High Potency & Schedule I-IVSpecialist potency handling
-
-
High Potency & Schedule I-IV
-
-
-
INSIGHT
Formulating And Delivering Psychedelics
A CDMO's View On The Possibilities Of Psychedelics
Learn more →
-
- Choose Upperton
-
-
Choose Upperton
-
-
-
Case studies
Rapid tech transfer to clinical manufacture
Read how we reached clinical dosing within three months, through strong communication, flexibility and responsiveness.
Read the case study →
-
- About us
-
-
About Upperton
-
-
- Resources
-
-
Resources
Popular filters
- Spray drying
- Inhalation
- Biologics
- Solubility
- Phase I-II
- Sterile fill-finish
-
Featured insight
Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy
Read more →
-
-
- Contact
-
-
What stage is your project?
- Pre-clinical
- Formulation Development
- Phase I-II Clinical Supply
- Process Scale-Up For Phase III
- Commercial
Get in touch
Call +44 (0) 115 855 7050
Visit: Trent Gateway, Technology Drive, Beeston, Nottingham, NG9 1LA
-
-
-
